January 06, 2025 01:46 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bharatiya Janata Party releases first list of candidates for Delhi Assembly polls, fields Parvesh Sahib Singh Verma against Kejriwal | Firecracker unit explosion in Tamil Nadu's Virudhunagar kills 6 | Body of independent journalist, who went missing on Jan 1, found in a septic tank in Chhattisgarh | Delhi: 14-year-old student stabbed to death outside school after brawl with classmate | Rohit Sharma confirms he is not retiring amid speculations after skipping Sydney Test | India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow
India-made Biological E's vaccine likely to be 90 pc effective; could be game-changer in fight against pandemic : Expert

India-made Biological E's vaccine likely to be 90 pc effective; could be game-changer in fight against pandemic : Expert

Jun 18, 2021, at 12:39 am

New Delhi/IBNS: Indigenously-made Biological E's anti-Covid19 jab, expected to have an efficacy of 90 per cent could be a gamechanger in the battle against the pandemic, according to a top doctor on a government advisory panel.

Covid19: Hyderabad based Biological E. inks deal with Canadian company to manufacture jabs in India

Covid19: Hyderabad based Biological E. inks deal with Canadian company to manufacture jabs in India

Jun 02, 2021, at 08:48 am

Hyderabad/IBNS: Hyderabad's Biological E. Limited has inked an agreement with Canada-based Providence Therapeutics to manufacture in its units mRNA coronavirus disease (Covid-19) vaccine, and run a pivotal trial in India for the jab.